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Summary 
Ligands for the cysteine-nch (CR)  domain of the mannose receptor (MR) were detected by 
incubating murine tissues with a chimeric protein containing CR fused to the Fc region of hu- 
man IgG1  (CR-Fc).  In naive mice, CR-Fc bound to sialoadhesin +,  F4/80 l°w/  , macrosialin  + 
macrophages (Mo) in spleen marginal zone (metallophilic Mo) and lymph node subcapsular si- 
nus. Labeling was also observed in B  cell areas of splenic white pulp. Western blotting analysis 
of spleen and lymph nodes lysates revealed a restricted number of molecules that interacted spe- 
cifically with  CR-Fc.  In immunized mice, labeling was  upregulated  on germinal centers  in 
splenic white pulp and follicular areas of lymph nodes. Kinetic analysis of the pattern of CR-Fc 
labeling in lymph nodes during a secondary immune response to ovalbumin showed that CR 
ligand expression migrated towards B cell areas, associated with cells displaying distincnve den- 
dritic morphology, and accumulated in developing germinal centers. These studies suggest that 
MR + cells or MR-carbohydrate-containing antigen complexes could be directed towards areas 
where humoral immune responses take place, through the interaction of the MR CR domain 
with molecules expressed in specialized macrophage populations and antigen transporting cells, 
T 
he mannose receptor (MR) l is a 175-kD type I trans- 
membrane  protein  expressed  in  macrophages  (Mo), 
dendritic cells  (1),  and hepatic endothelial cells,  that medi- 
ates  phagocytosis  of saccharide-coated particles  as  well  as 
pinocytosis of soluble glycoconjugates (2).  The expression 
of the MR is highly regulated; it appears only during ter- 
minal differentiation  of Mo  and  is  modulated by steroids 
and cytokines. In biogel polyacrylamide bead-elicited peri- 
toneal Mo MR mRNA and endocytic activity are down- 
regulated by IFN-~/and upregulated by IL-4 and IL-13 (3--5). 
Three types of domain have been described in the extracel- 
lular region of this molecule: a cysteine-rlch (CR)  domain 
that  contains  a  module  that resembles a  domain  of the B 
chain of the plant lectin Ricin (6), a domain with fibronec- 
tin type II repeats  (FNII), and  eight  C-type carbohydrate 
recognition  domains  (CRD)  that  mediate  ligand  binding 
1Abbreviations used in  this paper: CR,  cysteine-nch; CRD,  carbohydrate 
recogmtlon domain; CR1,  complement receptor 1;  CR-Fc,  cysteme 
nch-Fc chimera; FNII, fibronectm  type II; FDC, folhcular dendrinc cell; 
Mo, macrophage; MR,  mannose receptor; MZ, marginal zone; PNA, 
peanut agglutinin; Sn, slaloadhesm. 
(7-10).  Of these,  only CRDs 4-8 show affinity for carbo- 
hydrate  and only CRD4  exhibits multiple specificities  (9, 
10).  This structure IS conserved among the members of the 
"MR  family" that  includes  the  dendritic  cell  and  thymic 
epithelium marker DEC-205 (11), which contains 10 CRDs, 
and phospholipase A2 receptors (12,  13). 
No function has been found for the  CR and FNII do- 
mains of the MR, but amino acid sequence comparison be- 
tween the human and murine forms of the receptor shows 
86% identity in the case of the CR and 93% in the case of 
the FNII domain (4). Such a degree of conservation is sug- 
gestive of an important function  for these  regions.  In this 
study we have used chimeric proteins containing both CR 
and FNII domains or only the CR domain of the murine 
MR fused to the Fc region of human IgG1  (14),  to detect 
ligands  in  mouse  tissue.  In  non-immunized  mice,  both 
proteins bound equally to the marginal zone of spleen, the 
subcapsular sinus of lymph node and B  cell areas of splenic 
white  pulp.  Phenotypac  characterizanon  of the  cells  that 
express the  ligand(s)  will  be presented.  Several molecules 
that interact specifically with CR-Fc in Western blot anal- 
ysis, have been detected in spleen and lymph node protein 
lysates. 
1927  j. Exp. Med. © The Rockefeller University Press • 0022-1007/96/11/1927/11  $2.00 
Volume 184  November 1996 1927-1937 After  antigen  stimulation  ligand  activity  was  also  de- 
tected in germinal centers m  spleen and lymph nodes. Ki- 
netic studies showed that cells with ligand activity appeared 
to migrate towards B  cell areas and accumulate in develop- 
ing germinal centers of draining lymph nodes. These stud- 
ies indicate that  MR  (i.e.,  MR +  cells)  could be  directed, 
through its interaction with specific molecules expressed in 
spleen and lymph nodes via domain(s) not involved in car- 
bohydrate  recognition,  to  areas  where  attinity maturation 
of B  cell responses occur (i.e., the germinal center). 
Materials and Methods 
Animals.  C57B1/6, Balb/c and op/op mice were bred at the 
Dunn School  of Pathology and used at 7-8 wk of age.  Balb/c 
SCID mice were obtained from Harlan (Bicester, UK) and tissues 
from rag/rag rnlce were a kind gift from Dr. D. Kioussls (NIMR, 
Mill Hill, London). 
Antibodies.  The following rat mAb were prepared in our lab- 
oratory: Ser-4 and 3D6, used together to detect sialoadhesin (Sn) 
(15,  16),  F4/80, specific for a Mo plasma membrane differentia- 
tion  antigen  (17),  and  FAll  that  recognizes  rnacrosialin (18). 
Other antibodies used were: FDC-M1 (19), M5/114 (specific  for 
MHCII),  obtained from  the  Arnencan Tissue Type  Collection 
(Rockville,  MD),  8C12  (specific  for  complement  receptor  1, 
CR1)  (20),  and B220,  obtained from PharMingen (San Diego, 
CA).  Purified  human  IgG1  was  obtained from  Sigma  (Poole, 
Dorset, UK). 
Immunization.  Mice were primed subcutaneously in the back 
of the neck with OVA precipitated in alum (101) ~g) and 2 wk 
later challenged intraperitoneally (100 Ixg) or subcutaneously (50 lxg 
per limb) with the same antigen, as described elsewhere (21). 
Fc Chimeras.  Primers MP, I:5'GGGATATCGACCTTGGAC- 
TGAGCAAAGGGGCAACCTGG3'  and  MR.5:5'GGGAAT- 
TCACTTACCTGTCTCGCTTCCCTCAAAGTGCAATGG- 
ACAAAA3'  were  used  to  amplify  the  leader  sequence,  CR 
domain and FNII domain of the MR by RT-PCR using as tem- 
plate cDNA from biogel-eliclted peritoneal Mo that had been re- 
duced to express high levels of MR by IL-4 treatment (5 ng/ml), as 
described (3,  5).  To amplify only the leader sequence and CR 
domarn  a  new  primer  was  designed:  MR11:5'GGGAATTC- 
ACTTACCTGTGGAGTACATGGCTTCATATCCTCTCGA- 
GCA3'. MR1  contained an EcoRV site (underlined) and MR5 
and MR11  contained the splicing signal ACTTACCTGT  and 
an Ec___RoRI site  (underlined). PCR  products  were  digested with 
EcoRV and EcoP,  J, cloned into the piG expression vector (14), 
and sequenced. The chimeric proteins, CR and FNII domains, or 
CR domain of the MR alone, fused to the Fc portion of human 
IgG1  (CR-FNII-Fc and CR-Fc)  (see  Fig.  1 A),  were  purified 
from supernatants oftransfected Cos 7 cells by protein A chroma- 
tography  (Pharrnacla,  Uppsala,  Sweden).  CR-FNII-Fc  formed 
some aggregates after SDS-PAGE analysis, but a major band was 
observed of 65 kD under reducing conditions and  130-140 kD 
under non-reducing conditions. CR-Fc migrated as a single spe- 
cies in reducing and non-reducing SDS-PAGE, with a molecular 
mass of 50 and 100 kD, respectively (see Fig.  1 B).  Gel filtranon 
chromatography  on  a  Hfload  26/60  Superdex  200  pg  column 
(Pharmacia) showed that CR-Fc in solution behaves as the  ex- 
pected dimer with a size  of 105-110 kD  (data not shown). The 
chimeric proteins MAG1-5-Fc (22) and Snl-Fc (23) were kindly 
provided by Dr. Paul Crocker (IMM, Oxford, UK). 
Immunohistochemistry.  Organs  were  collected  and  frozen  in 
O.C.T. compound (BDH-Merck, Poole, Dorset, UK) cooled in 
isopentane over dry ice.  Frozen sections were  cut at 5 Ixm,  air- 
dried for 1 h, and stored at -20°C. Before staining, sections were 
thawed at room temperature for 1 h  and fixed for 10 man in 2% 
paraformaldehyde in Hepes-buffered isotonic saline at 4°C or in 
acetone at room temperature. In some cases, animals were perfu- 
sion-tLxed with 2% periodate-lysine-paraformaldehyde. After post- 
fixing in the same solution for 4 h, tissues were impregnated with 
20%  (wt/vol) sucrose in 0.1  M  phosphate buffer overrnght, be- 
fore freezing and sectioning. 
Fixed sections were washed in PBS containrng 0.1% (vol/vol) 
Tnton X-100 and endogenous peroxidase activity blocked by in- 
cubating sections with 10 -2 M  glucose, 10 -3 M  NAN3, 40 U  glu- 
cose  oxidase  (Sigma)  in 100 ml phosphate buffer for  15  min at 
37°C.  When chimeric proteins were  used,  sections were  incu- 
bated with 5% (vol/vol) normal goat or mouse serum (blocking 
buffer) for 30 rain and with hlgG1 or Snl-Fc, MAG1-5-Fc, CR- 
FNI1-Fc,  or  CR-Fc  proteins  diluted at  10  Ixg/ml rn blocking 
buffer for 60 min. Binding was detected by incubation ofsecnons 
with biotinylated goat  anti-human IgG  (Vector,  Peterborough, 
UK) or biotinylated mouse anti-human F(ab')2 (Jackson Immu- 
noResearch Labs., West Grove, PA)  diluted rn blocking buffer, 
followed by avidin-biotin-peroxidase complex (ABC elite; Vector) 
and 0.5 mg/rnl diarnrnobenzldlne (Polysciences Inc., Northamp- 
ton, UK) with 0.024% H20 2 in 10 rnM Imldazole in PBS, pH 
7.4. In the case of rat mAb, the blocking buffer was 5% (vol/vol) 
normal rabbit or mouse serum and a biotrnylated rabbit ann-rat 
IgG (Vector) or mouse anti-rat IgG (Fab')2 (Jackson)  was used to 
detect binding. Sections were  counterstained with crystal violet 
or  methyl  green.  In  the  case  of double  immunocytochemlstry 
with  CR-Fc  and rat Ab,  the  first  starnlng step with  the  above 
protocol was followed by blocking with avidin-biotrn (Vector). 
For the second step, avidin-biotrn-alkahne phosphatase complex 
(ABC-AP) and Vector blue detecnon system (Vector) were used. 
Cytospin  preparanons  were  air  dried  and  kept  at  -20°C. 
Before use, cells were fixed, permeabilized, and endogenous per- 
oxidase quenched as above. In this case blocking was performed 
,n 5%  (vol/vol) normal mouse serum in PBS.  Cells were  incu- 
bated  with  MAG1-5-Fc  or  CR-Fc  (10  Ixg/ml)  diluted in 5% 
normal mouse serum for  1  h,  and CR-Fc  binding detected  as 
above. Cells were  counterstained with hematoxylin. For double 
lrnrnunofluorescence on isolated cell preparations, fixed and per- 
rneabihzed cells were incubated in 5% (vol/vol) normal mouse se- 
rum for 30 rmn, followed by CR-Fc (10 btg/ml) and rat mAb di- 
luted In 5% (vol/vol) normal mouse serum for 60 ram. Binding 
was detected by incubation w~th biotmylated mouse anti-human 
F(ab')2 and  FITC-mouse anti-rat  IgG  (Fab')_~ (Jackson)  for  30 
turn and Texas red-avldin (Vector) for 30 min. 
Enrichment ofCR-Fc  + Cells.  Spleens and peripheral lymph nodes 
from normal mace were digested using 2.5% (wt/vol) collagenase 
D  and 0.1% DNase  (Boehringer Mannhmm, Lewes, East Sussex, 
UK)  in Iscove's modified Dulbecco's medmm (IMDM).  After 
digestion, erythrocytes in spleen were lysed following Gey's pro- 
cedure (24).  Cell suspensmns were washed and loaded on a per- 
formed continuous percoll gradient (Pharmacia) (1-2 ×  108 cells/ 
gradient)  and centrifuged at  400 g  for 30  rain.  The  two  major 
bands  (low  and  high  density  cells)  were  collected,  washed  m 
IMDM and prepared for analysis by irnmunocytochemlstry. 105 
cells were placed on poly L-lysine treated slides by centrifugatmn 
at 400 rpm for 5 min using a cytocentrifuge (Life Sciences Inter- 
national, Basingstoke, UK). 
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Figure 1.  (A) Schemanc representation of the structure of  the mannose 
receptor, and the chxmenc proteins CR-Fc and CP,-FNII-Fc. CP,, cys- 
telne-nch domain; FNII, fibronectm type II domain, CRD, carbohydrate 
recognmon domain. Shaded symbols ln&cate sugar bxndmg acuwty de- 
fined on model compounds (9,  10). (B) SDS-PAGE of purified CP,-Fc 
and CR-FNII-Fc under reducing and non-reducing condmons. 
Western Blotting Using CR-Fc.  Mouse  tissue  lysates  prepared 
in  2%  (vol/vol)  Triton  X-100  m  10  mM  tns-HC1,  150  mM 
NaC1, 2 mM EDTA, 10 mM NAN3, 5 mM iodoacetamlde,  2 mM 
PMSF,  1 ~g/ml pepstatin,  and  1 p.M  leupeptin were boiled in 
sample buffer (10 mM tns-HC1, pH 6.8,  2% SDS,  20% glycerol, 
0.001%  (wt/vol) bromophenol blue)  and resolved on a 6% SDS- 
PAGE. After electrophoresls,  proteins were transferred  to nitro- 
cellulose  (C-hybond; Amersham, Arnersham,  UK) and the filters 
blocked in 5% (wt/vol) nonfat milk in PBS,  0.1% Tween 20 for 
1 h and probed with CR-Fc (10 btg/ml in blocking buffer) for 1 h. 
Binding  was  detected  by  incubation  with  peroxidase-coupled 
anti-human IgG (Sigma)  diluted  1:5,000  in blocking buffer and 
chemiluminescence kit (ECL; Amersham). 
Results 
Localization  of Ligands for  the  CR  Domain  of the  MR  in 
Mouse  Tissue Sections by  Immunocytochemistry in  Normal  Mice. 
The CP, and FNII domains of the murine MR  or the CP,. 
domain alone were fused to the Fc portion of human IgG1 
(CP,-FNII-Fc and CR-Fc)  (Fig.  1) and used to label vari- 
ous  mouse  tissues  using  human  IgG1  or  other  chimeric 
proteins  (MAG1-5-Fc  and  Snl-Fc)  as  negative  controls. 
Identical labeling patterns  were observed in spleen  (Fig.  2, 
compare  row  C  with  D)  and  lymph  nodes  (data  not 
shown)  with  both  proteins  indicating  that  the  binding  of 
CP,.-FNII-Fc  was  due  to  its  CP,  domain.  In  naive  mice 
(Fig.  2,  column  1),  these  chimeric proteins  bound to cells 
located in the marginal zone (MZ) of the spleen (Fig. 2,  1C 
and  1D)  and  in  the  subcapsular  region  of lymph  nodes 
(LN) (see Fig. 4 B). There was no labeling in spleen (Fig. 2, 
rows A  and  B)  or LN  (see  Fig.  4  A)  with  other chimeric 
proteins or human IgG1 and CR-Fc binding was not influ- 
enced by the presence  of the Fc receptor blocking reagent 
2.4G2  (PharMingen;  data not shown). No specific binding 
was observed in lung, liver, muscle, skin (epidermis or der- 
mis),  brain  or bone  marrow  (data  not  shown).  In spleen, 
CR-FNII-Fc  and  CR-Fc  labeling  included  metallophilic 
MZ Mo which express high levels ofsialoadhesin (Sn)  (Fig. 2, 
compare 1C,  ID,  1G). Double immunolabefing using CR-Fc 
and 3D6/SER-4  (specific for Sn)  confirmed this  observa- 
tion (Fig. 3  C). CR ligand activity was absent in Sn + Mo in 
the outer MZ and in the red pulp  (Fig. 3, compare A  with 
B). Double immunolabeling using CR-Fc and F4/80 anti- 
body,  specific  for red  pulp  Mo  in  the  spleen,  established 
that neither probe bound to cells  in the  outer MZ  (Fig.  3 
D). CR-Fc+Sn  + metallophilic Mo also expressed the pan-Mo 
and  dendritic  cell  marker  macrosiahn  which  in  addition 
was found in red pulp, white pulp and outer MZ Mo (Fig. 
3  E). Weak CR-Fc labeling was detected in B  cell areas in 
the white  pulp  of normal  spleen  that are  strongly positive 
for complement receptor  1 (CR.1)  (Fig. 2,  1E)  and weakly 
positive for the follicular dendritic cell marker M1  (FDC-M1, 
Fig. 2,  IF). No labeling in T  cell areas was found. 
In unstimulated peripheral lymph nodes, CP,.-Fc binding 
was  detected  in  a  subpopulation  of Sn +  macrosialin +  Mo 
located in the subcapsular sinus  (Fig. 4, compare B,  C, D). 
Again no co-localization of CP,-Fc ligand(s)  (Fig. 4  B) and 
F4/80 (Fig. 4 F) was observed. 
The characterization ofMZ  CR-Fc + cells and subcapsu- 
lar  sinus  CR.-Fc  +  cells  as  Sn  +  macrosialin +  Mo  was  con- 
firmed  by  labeling  spleens  from  op/op  mice  which  lack 
MZ  and  MZ  metallophilic  Mo,  M-CSF-dependent  Mo 
populations  (25)  (Fig.  2,  column  3).  In these  animals  no 
CR.-Fc binding to the MZ  of spleen  (Fig.  2,  3C and 3D) 
and  no  3D6/SER-4  labeling  (Fig.  2,  3G)  were  detected. 
Similar results were obtained in the case of the subcapsular 
sinus of LN (data not shown). Work with op/op mice also 
showed that the labeling observed in follicular areas was in- 
dependent  of the  presence  of MZ,  because  CR-FNII-Fc 
and CR.-Fc still  bound to B  cell areas (CRA +, FDC-M1 +) 
(Fig. 2, compare 3C,  3D,  3E,  3F). 
CR-Fc binding was Ca  2+  and  ~+  "  -  Mg-  -independent,  be- 
cause  no  changes  in  the  labeling  pattern  were  noticed  in 
the presence  of EDTA  (data not shown).  CP,. binding ac- 
tivity was also T  and B  cell-independent;  CR-Fc bound to 
similar  areas  in  spleen  and  lymph  nodes  from  SC|D  and 
rag-/-  mice  though  the  abnormal  morphology  of the 
MZ in spleen  makes any precise  comparison difficult  (data 
not shown). 
Ex  Vivo Phenotypic Characterization of CR-Fc  + Cells.  The 
procedure  used to enrich  CP,-Fc +  cells was originally de- 
veloped to isolate follicular dendritic cells (FDCs) from im- 
mune lymphoid tissue (26). In the present case we used tis- 
sue  from  naive  animals  and  compared  the  cells  obtained 
from  collagenase  digested  spleen  and  lymph  nodes.  Cell 
suspensions were fractionated by percoll gradient and high 
and low density fractions collected as described in Materials 
and Methods. 
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Figure 3.  Characterisation  ofCK-Fc  + cells in situ. A and B show single staining, (A) SER-4/3D6 (specific  for Sn; peroxidase, brown) and (B) CR-Fc 
(alkaline phosphatase, blue). (C-F) double immunostaining of spleen sections with CR-Fc (blue) and different markers (brown); (C) CR-Fc and SER-4/ 
3D6; (D) CR-Fc and F4/80; (E) CR-Fc and FAll (specific  for macroslalin); (F) CR-Fc and 8C12 (specific for CR1). Purple cells observed in C and E 
represent double-labeled cells, mainly MZ metallophilic Mo. 
Immunocytochemical  analysis  of cytospin  preparations 
from both cell populations was performed with CR-Fc to 
estimate  enrichment  of CR-Fc +  cells.  These  cells  were 
found in the  low density fraction where  they represented 
less than 0.1% of total cells.  No significant number of CR- 
Fc  + cells was found in the high density fraction. No FDC- 
M1 + cells were obtained from non-immunized mice under 
these  conditions.  CR-Fc  +  cells  appeared large with  cyto- 
plasmic processes and were isolated or part of cellular clus- 
ters.  They  contained  a  granular  cytoplasm  and  CR-Fc 
staining  was  localized  strongly but  not  exclusively  to  the 
plasma  membrane  (Fig.  5).  Double  immunofluorescence 
showed that most CR-Fc + cells isolated from naive animals 
are macrosialin +, Sn  +, MHCII  l°w/-, F4/8(~  °w/-, CR1 neg- 
ative,  and B220 negative  (data not shown).  Therefore the 
populations  of CR  binding  cells  isolated  following  this 
method  are  likely  to  represent  mainly  MZ  metallophilic 
Mo from spleen and subcapsular sinus Mo from LN. 
Detection of Molecules with CR Binding Activity.  Blotting of 
normal tissue lysates with CR-Fc allowed the characteriza- 
tion of molecules that interact with CR. As shown in Fig. 6, 
several proteins  ranging in size from 80 to more than 300 
kD were  specifically recognized by CR-Fc  in  spleen  and 
LN lysates.  No proteins were detected by CR-Fc in liver 
lysates (which totally lack reactivity with CR-Fc by immu- 
nocytochemistry) or by other control chimeric proteins in 
any of the lysates tested. 
This complex pattern was highly reproducible,  was ob- 
tained with CR-FNII-Fc and CR-Fc (data not shown) and 
was independent of the detergent used to prepare the lysate 
([3-octylglucoside,  CHAPS,  or NP-40).  In an  attempt  to 
increase  sensitivity,  lysates were immunoprecipitated  with 
CR-Fc,  electrophoresed  under  non-reducing  conditions, 
blotted,  and incubated with CR-Fc conjugated to digoxi- 
genin followed by an anti-digoxigenin antibody. No differ- 
ences were observed (data not shown). 
Figure  2.  CR-FNII-Fc and CR-Fc staining in spleen. Staining of serial spleen sectiom from normal (1), immunized (2), and op/op mice (3) with 
MAG1-5IFc (A), Sn 1-Fc (B), CR-FNII-Fc (C), CR-Fc (/2)), 8C12, specific for CR1 (E), FDC-M1 (F), and SER-4/3D6, specific for Sn (G). Immu- 
nized mice (column 2) were primed subcutaneously  with OVA precipitated m alum and 2 wk later challenged intraperitoneally with the same antigen. 
Spleens were collected 10 d after secondary  immunisation. Presence of  germinal centres was determined by PNA labeling (data not shown). 
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Figure  4.  CR-Fc  labehng  in 
lymph  nodes.  Serial  penpheral 
lymph  node  secnons  from  nor- 
real  mace  were  treated  as  de- 
scribed m Materials and Methods 
with  human  IgG1  (A); CR-Fc 
(B); FAll  (C); SER-4/3D6  (D); 
8C12  (E);  and  F4/80  (F).  Note 
absence  of  CR-Fc  labehng  of 
medullary Sn + FAll + cells. 
Localization of Ligands for CR-Fc in Immunized Mice.  Af- 
ter induction  of germinal  center  formation  in  normal  mouse 
spleen by immunization  with  OVA  (Fig.  2,  column  2),  CR- 
FNII-Fc  and  CR-Fc  also  labeled  germinal  centers  and  co- 
localized  with  CR1  and  FDC-M1  which  are both  upregu- 
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lated  under  these  conditions  (Fig.  2,  compare  2C  and  2D 
with  2E and  2F).  Similar results  were  observed  in germinal 
centers  generated  in  draining  LN  after  subcutaneous  im- 
munization  (data  not shown). 
These  findings  were  suggestive  of  a  role  for  the  CR 
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Figure  5.  Isolated  CR.-Fc + 
cells.  Cytospin  preparanons  of 
low  denstty  cells  prepared  from 
naive  animals  as  described  in 
Matenals  and  Methods,  from 
spleen  (A-C)  and  lymph  nodes 
(D-F), stained with MAG 1-5-Fc 
(A  and  D)  or CR-Fc  (B,  C,  E, 
and F). Magnificanon  × 100. 
1932  Mannose Receptor Cysteine-rich Domain Ligand MAG-Fc  CR-Fc 
L  S  LN  L  S  LN 
220- 
97.4- 
;  ~¢c, 
Figure 6.  Biochemical  charac- 
terisation of CR ligand(s). De- 
tection  of putatlve hgands for 
CR-Fc by Western blot analysis 
of total protein lysates  from  liver 
(L), spleen (S)  (300 ~g of pro- 
tern/well), and penpheral lymph 
nodes  (LN) (100 ~g  of pro- 
tern/well) electrophoresed  under 
non-reducing  conditions, with 
MAG1-5-Fc and CR-Fc. 
ligand or CR ligand bearing cells during immune responses. 
To  investigate this possibility the  time course  of localiza- 
tion of CR-Fc binding in LN during a secondary immune 
response was studied. As shown in Fig. 7, changes in CR-Fc 
labehng were observed at different times during a second- 
ary  response  to  ovalbumin.  Background  labeling  using  a 
control  chimeric  protein was minimal  (Fig.  7  A).  Before 
injection  (Fig.  7  /3,  Day 0)  the  CR-Fc protein bound  to 
cells restricted to the subcapsnlar sinus and trabeculae enter- 
ing the tissue. Within 24 h of antigenic challenge (Fig. 7  C), 
labeling appeared to move into the first layers of lympho- 
cytes.  CR  binding activity continued  to  move deeper by 
48  h  (Fig.  7  D),  with  CR-Fc  +  cells  displaying distinctive 
dendritic  processes that  could be especially seen by day 3 
(Fig.  7 E). At this point the label appeared to have begun to 
accumulate in the B cell follicles as well as to move towards 
the  paracortex.  Interestingly,  as seen by day 4  (Fig.  7  F), 
cells  generating the FDC network (arrows) in the develop- 
ing germinal center (PNA labeling; serial section, Fig. 7 K) 
also  bound the  CR-Fc protein; labeling diminished as the 
other positive cells approached the T  cell zone. This disap- 
pearance may indicate that the ligand was internalized and 
degraded.  From day 5  (Fig.  7  G) onward (Fig.  7, H, I, and 
J,  respectively, days 6,  10,  and  12),  labeling became more 
restricted  to  the  subcapsular  sinus  and  the  FDC  network 
(Fig.  7,  G-J, arrows) within germinal centers (PNA labeling 
serial sections,  Fig.  8,  L-O,  days 5,  6,  10,  and  12,  respec- 
tively). By day 12,  the distribution resembled that of day 0 
with the additional labeling of the antigen-retaining FDCs. 
These results show that during an immune response CR- 
Fc binding activity moved towards the follicles and became 
concentrated in the germinal centers. 
Discussion 
MR plays an important role in endocytosis and phagocy- 
tosis of sugar bearing molecules and particles. As such,  the 
focus of studies to date has been on the domains involved in 
carbohydrate recognition (CRDs), defining receptor speci- 
ficity, binding properties  (9,  10),  and  its  intracellular traf- 
ficking (2).  The most conserved regions between the  hu- 
man and routine  forms of the  MR  are the  CR  and  FNII 
1933  Martinez-Pomares et al. 
domains  which  are  located  at  the  amino  terminus  of the 
molecule  (4).  This degree of conservation as well as their 
localization  at  the  same  region  in  other  members  of the 
MR  superfamily, i.e.,  DEC205  and phospholipase A2  re- 
ceptors,  suggest  an  important  role  for these  domains  that 
might be common to  all these proteins.  Our results show 
that there is/are ligand(s)  for the CR domain of the murine 
form of the  MR  in mouse spleen and lymph nodes.  Our 
strategy involved the use of Fc chimeric proteins contain- 
ing either both CR and FNII domains of the MR.,  or the 
CR domain alone (Fig.  1 A), to search for hgands in mu- 
rine tissues.  The observation that CR-FNII-Fc and CR-Fc 
showed identical labeling patterns (Fig.  2,  compare row C 
with D)  suggested that their binding was due to the pres- 
ence  of the  CR  domain  alone  and  that  this  region  has  a 
similar  conformation in  both  proteins.  Further  character- 
ization of the molecule(s) that interact with CR will allow 
us to test if the CR domain as part of the whole MR mol- 
ecule,  behaves  in  the  same  way  as  in  CR-FNII-Fc  and 
CR-Fc. The possible binding of CR-Fc through Fc recep- 
tors in the tissue labeling experiments was excluded by the 
addition  of  normal  mouse  serum  and  the  Fc  receptor 
blocking antibody 2.4G2  (data not shown)  and the use of 
other  Fc  chimeric proteins  (MAG1-5-Fc  and  Snl-Fc)  or 
human IgG1  as controls.  All the  results indicated  that the 
interaction  of CR-Fc  with  its ligand(s)  was not  mediated 
by its Fc region. 
In tissue  sections from normal mice,  CR-FNII-Fc and 
CR-Fc mostly bound to two subpopulations ofF4/80 -/l°w, 
M-CSF-dependent (Fig.  2, 3C and 3D) Mo which express 
macrosialin (FAll +) and the adhesion molecule Sn (SER- 
4/3D6+):  MZ  metallophilic Mo in  spleen  (Figs.  2  and 3) 
and Mo in the subcapsular sinus of LN (Fig. 4). Not all Sn ÷ 
cells are recognized by CR-Fc; red pulp and outer MZ Mo 
(Sn  l°w) in the spleen and medullary Mo (Sn  h~gh) in the LN, 
as well as other Sn + cells located in other organs (data not 
shown),  do  not  interact  with  this  protein.  Detection  of 
CR-Fc +  cells  after collagenase  digestion  and  selection  of 
low density cells  of spleen and LN, confirmed that ligands 
for CR  are cell associated and that only a fraction of Sn  + 
cells bound CR-Fc. Therefore CR-Fc recognized special- 
ized Mo populations that express the Mo restricted marker 
Sn and lack the Mo differentiation antigen F4/80. 
Areas where most CR-Fc  + cells are located in naive ani- 
mals are thought to be involved in cell and antigen traffick- 
ing.  Previous  studies  have  described  binding  of lympho- 
cytes  (27-30),  macrophages  (31),  dendritic  cells  (32),  as 
well as of exogenous antigens  (33,  34)  to splenic MZ  (35) 
or to the subcapsular sinus of LN (30,  31). 
Additional weaker staining with CR-Fc was observed in 
follicular  areas  (CR1 +,  Fig.  2  1E,  Fig.  3  F)  in  normal 
splenic  white  pulp,  which  we  have not  yet assigned to  a 
specific cell type; no FAll-,  Sn-  cells  that bound CR-Fc 
were  found  after spleen  or  LN  digestion  suggesting  that 
CR-Fc + follicular cells were not isolated by this procedure. 
Specific follicular labeling correlated with the degree of an- 
tigen stimulation, was more commonly found in spleen and 
mesenteric lymph nodes than in the peripheral lymph nodes ::,, 
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1934  Mannose  Receptor Cysteine-rich Domain Ligand of naive  animals  and  varied  among mice  independent  of 
the  constant  presence  of Clq,-Fc  binding  activity  in  the 
subcapsular sinus of LN and MZ of spleen. In particular, la- 
beling of op/op mouse spleens  (Fig. 2, column 3) showed 
that this follicular label was present in the absence of MZ 
Mo.  After immunization with  ovalbumin,  follicular label- 
ing increased markedly in spleen and LN; it was located in 
germinal  centers  and  co-localized  with  CR.I,  the  FDC 
marker  FDC-M1  (36)  (Fig.  2,  compare 2C and  2D with 
2E and 2F) and PNA labeling (data not shown). 
To identify the origin of the follicular labeling observed 
after antigen stimulation,  peripheral lymph nodes collected 
at  different  times  during  a  secondary  immune  response 
were  labeled  with  CR.-Fc.  The  results  from  this  experi- 
ment, shown in Fig. 7, suggested that the origin of the fol- 
licular staining could be the concentration of CR-binding 
cells in this area. Early after immunization CR` binding ac- 
tivity,  associated with  cells  that were  dendritic  in appear- 
ance, seemed to migrate towards the B and T  cell areas and 
then became localized in germinal  centers.  This  could be 
due  to  the  movement of CR`-Fc  +  cells  or the  transfer  of 
CR. ligand(s)  from one cell type to another.  According to 
our results,  the time  course of Ctk-Fc +  cells  moving into 
these  regions paralleled  the  kinetics  for the  movement of 
antigen into germinal centers reported by Szakal et al.  (37), 
and these cells  may correspond to the antigen transporting 
cells  characterized by these authors. 
Five species of Ctk binding proteins have been detected 
in  protein  lysates  from  spleen  and  lymph  nodes  (Fig.  6) 
which raised concern about the specificity of CR.-Fc in this 
assay.  Because the patterns obtained were highly reproduc- 
ible and specific for the organs where CR binding was de- 
tected,  and because no other chimeric proteins recognized 
any of these species, we consider these proteins to be puta- 
tive ligands for the CR domain of the MR.. Their nature is 
undefined;  they could represent  multimers,  different spliced 
or cleaved forms  of the  same  molecule  or distinct  mole- 
cules  that  share  the  same  CI~  binding  motif.  Nor  is  it 
known whether particular cells that bind CR`-Fc by immu- 
nocytochemistry express all  of these molecular species  de- 
tected in tissue lysates. Experiments are in progress to purify 
the putative ligand(s)  from spleen lysates,  and to characterize 
the nature of their interaction with the CR  domain of the 
MR.  At the  same  time  comparison between  the  patterns 
obtained  with  tissues  from naive  and  immunized  mice is 
under way to characterize molecules that could be upregu- 
lated aRer antigen stimulation. 
The data presented in this study indicate that MR is able 
to interact  through its  CR` domain with hgands expressed 
by cells located in areas involved in cell and antigen trans- 
port and regulated by antigen stimulation.  The binding of 
the  CR  domain  to ligands  could mediate  the  trapping  of 
MR +  cells  (Mo  and  dendritic  cells)  and  their  delivery  to 
follicular  areas.  The  relevance  of the  interaction  between 
MZ  metallophilic  and  subcapsular  sinus  Mo  with  MR + 
cells through the MR., a receptor that mediates phagocyto- 
sis and endocytosis, is not clear. A possibility we considered 
is the  existence  of a soluble form of the MR,  as has been 
described  for  the  human  180-kD  receptor  for  secretory 
phospholipases A 2 (12), that could be trapped by cells bear- 
ing CR. ligands  and  transported  to follicular areas.  Such a 
form has recently been found in supernatants from biogel- 
elicited peritoneal Mo (Martinez-Pomares, L., J. Mahoney, 
and S. Gordon, manuscript in preparation),  but no in vivo 
data  are yet available.  We postulate  that  carbohydrates  or 
carbohydrate-bearing molecules could be directed, through 
their  binding  to  the  CRDs  of the  mannose  receptor  and 
subsequent interaction of the complex with the CR-ligand(s), 
to B  cell areas  in a  way similar  to  complement and  anti- 
body-bound antigens. This would be an alternative mecha- 
nism for the transport of native antigens to sites where high 
affinity B  cells responses are occurring. 
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Figure 7.  Expression  ofCR ligand during an immune response. Mice were primed behind the neck with ovalbumin precipitated in alum and 4 wk 
later, challenged  with the same antigen m each limb. The drainmg lymph nodes were taken at 24-h intervals until day 12 (C, day 1; D, day 2; E, day 3; F 
and K, day 4; G and L, day 5; H and M, day 8; I and N, day 10;J and O, day 12) as well as before the secondary  immunisation (A and B). Sections were 
stained as described in Materials and Methods with control cbameric protein (A), CR-Fc (B-J), and PNA (K-O). 
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